A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach

Michal Haran, Vita Mirkin, Andrei Braester, Nurith Harpaz, Olga Shevetz, Marina Shtreiter, Shulamit Greenberg, Orly Mordich, Orna Amram, Inbal Binsky-Ehrenreich, Ayelet Marom, Idit Shachar, Yair Herishanu, Rosa Ruchlemer, Alain Berrebi, Liora Valinsky, Mordechai Shtalrid, Lev Shvidel

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)125-128
Number of pages4
JournalBritish Journal of Haematology
Volume182
Issue number1
DOIs
StatePublished - Jul 2018

Funding

FundersFunder number
Israel Cancer Association

    Keywords

    • Phase I clinical trial
    • chronic lymphocytic leukaemia
    • elderly patients
    • milatuzumab
    • performance status

    Cite this